Navigating the research peptide marketplace requires selecting a supplier that guarantees chemical purity, verified lot-specific analytical documentation, and reliable US-based fulfillment. PX1 Research provides high-purity Cartalax tripeptide synthesized under strict quality protocols for in vitro and preclinical laboratory applications.
Navigating the research peptide marketplace requires selecting a supplier that guarantees chemical purity, verified lot-specific analytical documentation, and reliable US-based fulfillment. PX1 Research provides high-purity Cartalax tripeptide synthesized under strict quality protocols for in vitro and preclinical laboratory applications.
The best place to buy Cartalax is from a dedicated domestic supplier like PX1 Research that provides lot-specific, third-party Certificate of Analysis (COA) verification using High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS). PX1 Research ensures high purity (>98%), low endotoxin levels, domestic US manufacturing, and immediate same-day shipping from dual fulfillment facilities in California and Arizona.
When purchasing synthetic peptides for experimental protocols, investigators must avoid commercial vendors that lack transparent analytical reporting or fail to provide comprehensive structural identity data. PX1 Research operates strictly within the laboratory supply domain, ensuring every vial of Cartalax tripeptide fulfills rigorous research-grade specifications.
Cartalax is a synthetic short bioregulator tripeptide composed of three amino acid residues: L-alanine, L-glutamic acid, and L-aspartic acid (Ala-Glu-Asp or AED). It belongs to a specialized class of low-molecular-weight peptide bioregulators developed to study cell-specific transcription, gene expression, and extracellular matrix interactions in cartilage and connective tissues.
Due to its compact molecular weight (approximately 347.3 g/mol), Cartalax readily interacts with nuclear chromatin and cell culture models without requiring complex carrier proteins. Researchers studying tissue biology utilize Cartalax to observe cellular responses in chondrocytes, synovial fibroblasts, and osteoblasts under controlled in vitro environments. To explore similar short-chain regulatory molecules, explore our full catalog of all research peptides.
In vitro data indicate that Cartalax modulates the functional activity of primary chondrocytes by interacting with specific histone proteins and region-specific DNA sequences. Preclinical studies suggest that the Ala-Glu-Asp sequence plays a regulatory role in maintaining extracellular matrix structural integrity by promoting the gene expression of aggrecan, collagen type II, and endogenous glycosaminoglycans in tissue culture systems.
Animal study models evaluating connective tissue homeostasis have observed that exposure to Cartalax influences local cytokine production, downregulating pro-inflammatory signal transducers such as IL-1β and TNF-α while supporting physiological protein synthesis. Researchers investigating cartilage degradation and cellular aging frequently analyze Cartalax within broader comparative studies examining cellular repair cascades. Further biological context can be explored via the PX1 research hub.
Identifying a trustworthy supplier for research-grade compounds requires a detailed audit of quality assurance parameters. Because experimental reproducibility depends entirely on chemical identity and lack of contaminants, lab managers should evaluate prospective suppliers against five crucial benchmarks:
1. Lot-Specific Analytical Testing: Every batch must be independently analyzed by an ISO 17025-accredited laboratory using RP-HPLC to verify chemical purity and Mass Spectrometry to confirm exact molecular mass. 2. Endotoxin Quantification: Chemical reagents destined for cell culture assays must undergo Chromogenic LAL testing to ensure bacterial endotoxin levels remain below strict limits (typically <0.01 EU/mg). 3. Transparent Manufacturing: Synthesis should occur in GMP-compliant facilities adhering to standardized solid-phase peptide synthesis (SPPS) procedures. 4. Complete Supply Chain Traceability: Product lots must feature traceable batch numbers matched directly to public COAs. 5. Secure Domestic Shipping: USA-based inventory avoids international customs delays, thermal degradation during transit, and import compliance risks.
PX1 Research was founded to eliminate ambiguity in the scientific reagent sector. Every batch of Cartalax supplied by PX1 undergoes dual analytical verification. We publish full-spectrum RP-HPLC chromatograms and MS spectra directly for researcher inspection, ensuring complete transparency prior to acquisition.
Synthesized domestically within ISO-standard facilities, PX1 peptides undergo stringent lyophilization to maintain maximal structural stability during transport. Operating dual fulfillment centers in California and Arizona allows PX1 Research to offer same-day shipping on orders placed Monday through Friday, safeguarding thermal stability and minimizing operational downtime for active laboratories.
In musculoskeletal and extracellular matrix research, Cartalax is often studied alongside or compared against other peptide compounds targeting cellular signaling and repair pathways. Understanding how Cartalax differs structurally and functionally from alternative agents helps investigators select the correct research candidate for specific assay designs.
While Cartalax (Ala-Glu-Asp) acts primarily as a short chromatin-interacting bioregulator targeting chondrocyte gene transcription, larger synthetic peptides operate through distinct cell-surface receptor pathways. For instance, BPC-157 is a 15-amino acid pentadecapeptide widely evaluated in animal models for its vascular endothelial growth factor (VEGF) pathway activation and soft tissue healing dynamics. Similarly, TB-500 research focuses on actin-sequestering mechanisms via G-actin regulation, whereas KPV peptide research explores anti-inflammatory tripeptide signaling via NF-κB inhibition. Researchers interested in gene expression modulation frequently compare Cartalax with broad-spectrum regulatory compounds detailed in our bioregulator peptides overview.
Cartalax is supplied as a sterile, lyophilized (freeze-dried) white powder packaged in sealed glass vials. To preserve peptide integrity and prevent chemical degradation, research personnel must follow standard aseptic laboratory protocols upon receipt:
Lyophilized Cartalax should be stored at -20°C or -80°C for long-term storage, shielded from light and moisture. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent condensation inside the container. Cartalax exhibits high solubility in sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or sterile water for injection. Once reconstituted, liquid aliquots should be maintained at 4°C for short-term utilization or sub-aliquoted and stored at -20°C to avoid repeated freeze-thaw cycles.
A Certificate of Analysis (COA) serves as the definitive proof of peptide purity and identity. When evaluating Cartalax COAs, research buyers should confirm that the report reflects the exact lot number printed on the physical vial.
The High-Performance Liquid Chromatography (RP-HPLC) trace must show a single dominant, symmetrical peak corresponding to Cartalax, with integration demonstrating at least 98% area purity. Secondary minor peaks represent minor synthesis side-products or deletion sequences. Mass Spectrometry (MS) analysis must display a major molecular ion peak matching the theoretical monoisotopic mass of Cartalax (347.3 Da). Vendors offering generic or unlinked COAs fail to satisfy scientific control standards.
PX1 Research accommodates research operations of all scales, from individual academic preliminary assays to large-scale institutional study series. Vials are packaged under inert argon gas shielding to maximize shelf stability during storage.
Principal investigators, university departments, and contract research organizations (CROs) requiring multi-gram quantities or recurring delivery schedules can set up a dedicated bulk lab account. Bulk accounts grant access to dedicated account management, custom batch synthesis options, and prioritized analytical processing.
What is Cartalax intended for in a laboratory setting?
Cartalax is supplied exclusively as a research-grade chemical compound for in vitro cell culture assays, biochemical analysis, and preclinical animal research. It is not intended for human or veterinary use.
How does PX1 Research verify the purity of Cartalax?
Every lot of Cartalax undergoes third-party testing at ISO 17025-accredited analytical laboratories. Purity is confirmed via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and structural identity is verified using Mass Spectrometry (MS).
What is the sequence and molecular weight of Cartalax?
Cartalax is a tripeptide with the amino acid sequence L-Alanine-L-Glutamic Acid-L-Aspartic Acid (Ala-Glu-Asp / AED). Its theoretical molecular weight is approximately 347.3 g/mol.
What reconstituted solvents are recommended for Cartalax assays?
Cartalax is freely soluble in aqueous solvents including sterile bacteriostatic water, sterile normal saline, or standard cell-culture buffer solutions such as phosphate-buffered saline (PBS, pH 7.4).
Are endotoxin levels tested for PX1 Research Cartalax?
Yes. PX1 Research conducts LAL (Limulus Amebocyte Lysate) endotoxin testing on research peptide lots to ensure compatibility with sensitive cell culture and in vitro models.
Where does PX1 Research ship Cartalax from?
All PX1 Research compounds are manufactured and stored in the United States. Orders are fulfilled and shipped same-day (Monday through Friday) from our logistics facilities located in California and Arizona.
How should reconstituted Cartalax be stored?
Reconstituted Cartalax solutions should be stored at 4°C for short-term experimental use (up to 7-14 days) or sub-aliquoted and stored at -20°C to -80°C to prevent degradation from repeated freeze-thaw cycles.
Can I obtain a bulk quantity of Cartalax for an institutional study?
Yes. Institutional buyers and commercial research organizations can apply for a wholesale research account to obtain volume pricing, batch reservations, and custom synthesis support.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.